Continuous Labor Epidural Catheter for Tubal Ligation Study
NCT ID: NCT00898443
Last Updated: 2012-08-07
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
18 participants
INTERVENTIONAL
2008-10-31
2010-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Spinal Anesthetic Group
This group will receive spinal anesthetic for the surgical procedure and will serve as the control group for this study.
Spinal anesthetic
This group was assigned to receive spinal anesthetic for postpartum tubal ligation.
Epidural Anesthetic Group
This is the experimental group for this study.
Epidural anesthetic
Use of the existing continuous labor epidural for surgical anesthetic for postpartum tubal ligation
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Epidural anesthetic
Use of the existing continuous labor epidural for surgical anesthetic for postpartum tubal ligation
Spinal anesthetic
This group was assigned to receive spinal anesthetic for postpartum tubal ligation.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Functional epidural catheter placed for labor and delivery analgesia
* The epidural is still taped within 1cm of the original depth when it was functional for labor analgesia
* 1-45 years of age
Exclusion Criteria
* History of dural puncture ("wet tap") during initial epidural catheter insertion
* History of marginal or inadequate epidural analgesia for labor
* Cesarean section for delivery
* Examination demonstrates that the indwelling catheter has migrated more than 1 cm from the original depth when secured
* The end of indwelling epidural catheter appears to have not been capped appropriately or the cap was not maintained intact
* Prolonged sensory or motor block, bladder or anal sphincter dysfunction, nerve damage, inability to ambulate, post-dural puncture headache (PDHD), or seizures, during or after delivery and following cessation of the epidural catheter dosing
* Pseudocholinesterase deficiency
* Allergy to Nesacaine® (chloroprocaine) or lidocaine
* General anesthesia provided for delivery
* History of substance abuse disorder
* History of major psychiatric disorder
* Non-English reading/speaking participants
19 Years
45 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Alabama at Birmingham
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Marsha Wakefield, MD
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Marsha L. Wakefield, MD
Role: PRINCIPAL_INVESTIGATOR
UAB Department of Anesthesiology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Alabama at Birmingham
Birmingham, Alabama, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
F080829007
Identifier Type: -
Identifier Source: org_study_id